| Dr Carlos Elvin Diaz, MD | |
|
1515 S 8th St, Deming, NM 88030-4940 | |
| (575) 544-3937 | |
| (575) 546-2870 |
| Full Name | Dr Carlos Elvin Diaz |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 28 Years |
| Location | 1515 S 8th St, Deming, New Mexico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093797011 | NPI | - | NPPES |
| Z163113 | Other | AZ | MEDICARE PIMA PTAN |
| MD2014-0132 | Medicaid | NM | |
| 878342 | Medicaid | AZ |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Barnet Dulaney Perkins Eye Center, Pc | 0749288298 | 95 |
News Archive
Montana State University scientists concerned about lethal mold infections have found a gene that regulates the mold's resistance to drugs.
Researchers found that the death rate among children diagnosed with severe falciparum malaria was almost one-fourth lower when they received the drug artesunate rather than the standard treatment of quinine, according to research which was presented at the American Society for Tropical Medicine and Hygiene (ASTMH) over the weekend and published Monday in the Lancet, HealthDay News/U.S. News and World Report writes.
In a speech to the Dallas Friday Group today, John C. Lechleiter, Ph.D., chairman, president and CEO of Eli Lilly and Company, said that the value of medical innovation – particularly innovative medicines – far outstrips its cost. Lechleiter marshaled data showing that medical innovation over the past century dramatically extended life spans, improved quality of life, and boosted productivity.
A new study developed at the Center for Gastrointestinal Cancer Research and the Center for Epigenetics, Cancer Prevention and Cancer Genomics at Baylor Research Institute has discovered unique metastasis-specific microRNA signatures in primary colorectal cancers that could predict prognosis and distant metastasis in colorectal cancer.
› Verified 6 days ago
| Entity Name | Southwestern Eye Center, Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023063187 PECOS PAC ID: 1850296989 Enrollment ID: O20031203000181 |
News Archive
Montana State University scientists concerned about lethal mold infections have found a gene that regulates the mold's resistance to drugs.
Researchers found that the death rate among children diagnosed with severe falciparum malaria was almost one-fourth lower when they received the drug artesunate rather than the standard treatment of quinine, according to research which was presented at the American Society for Tropical Medicine and Hygiene (ASTMH) over the weekend and published Monday in the Lancet, HealthDay News/U.S. News and World Report writes.
In a speech to the Dallas Friday Group today, John C. Lechleiter, Ph.D., chairman, president and CEO of Eli Lilly and Company, said that the value of medical innovation – particularly innovative medicines – far outstrips its cost. Lechleiter marshaled data showing that medical innovation over the past century dramatically extended life spans, improved quality of life, and boosted productivity.
A new study developed at the Center for Gastrointestinal Cancer Research and the Center for Epigenetics, Cancer Prevention and Cancer Genomics at Baylor Research Institute has discovered unique metastasis-specific microRNA signatures in primary colorectal cancers that could predict prognosis and distant metastasis in colorectal cancer.
› Verified 6 days ago
| Entity Name | Barnet Dulaney Perkins Eye Center, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376574707 PECOS PAC ID: 0749288298 Enrollment ID: O20061117000349 |
News Archive
Montana State University scientists concerned about lethal mold infections have found a gene that regulates the mold's resistance to drugs.
Researchers found that the death rate among children diagnosed with severe falciparum malaria was almost one-fourth lower when they received the drug artesunate rather than the standard treatment of quinine, according to research which was presented at the American Society for Tropical Medicine and Hygiene (ASTMH) over the weekend and published Monday in the Lancet, HealthDay News/U.S. News and World Report writes.
In a speech to the Dallas Friday Group today, John C. Lechleiter, Ph.D., chairman, president and CEO of Eli Lilly and Company, said that the value of medical innovation – particularly innovative medicines – far outstrips its cost. Lechleiter marshaled data showing that medical innovation over the past century dramatically extended life spans, improved quality of life, and boosted productivity.
A new study developed at the Center for Gastrointestinal Cancer Research and the Center for Epigenetics, Cancer Prevention and Cancer Genomics at Baylor Research Institute has discovered unique metastasis-specific microRNA signatures in primary colorectal cancers that could predict prognosis and distant metastasis in colorectal cancer.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Carlos Elvin Diaz, MD 4800 N 22nd St, Phoenix, AZ 85016-4701 Ph: (602) 955-1000 | Dr Carlos Elvin Diaz, MD 1515 S 8th St, Deming, NM 88030-4940 Ph: (575) 544-3937 |
News Archive
Montana State University scientists concerned about lethal mold infections have found a gene that regulates the mold's resistance to drugs.
Researchers found that the death rate among children diagnosed with severe falciparum malaria was almost one-fourth lower when they received the drug artesunate rather than the standard treatment of quinine, according to research which was presented at the American Society for Tropical Medicine and Hygiene (ASTMH) over the weekend and published Monday in the Lancet, HealthDay News/U.S. News and World Report writes.
In a speech to the Dallas Friday Group today, John C. Lechleiter, Ph.D., chairman, president and CEO of Eli Lilly and Company, said that the value of medical innovation – particularly innovative medicines – far outstrips its cost. Lechleiter marshaled data showing that medical innovation over the past century dramatically extended life spans, improved quality of life, and boosted productivity.
A new study developed at the Center for Gastrointestinal Cancer Research and the Center for Epigenetics, Cancer Prevention and Cancer Genomics at Baylor Research Institute has discovered unique metastasis-specific microRNA signatures in primary colorectal cancers that could predict prognosis and distant metastasis in colorectal cancer.
› Verified 6 days ago
Dr. Thomas Martin Boyle, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 850 W Florida St, Deming, NM 88030 Phone: 575-544-2020 Fax: 575-544-2801 |